Cubist Systematic Strategies’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-196
| Closed | -$22K | – | 2574 |
|
|
2020
Q1 | $22K | Buy |
196
+97
| +98% | +$10.9K | ﹤0.01% | 2062 |
|
|
2019
Q4 | $24K | Sell |
99
-215
| -68% | -$52.1K | ﹤0.01% | 2333 |
|
|
2019
Q3 | $108K | Sell |
314
-394
| -56% | -$136K | ﹤0.01% | 1926 |
|
|
2019
Q2 | $652K | Sell |
708
-475
| -40% | -$437K | 0.01% | 1308 |
|
|
2019
Q1 | $1.89M | Buy |
1,183
+1,027
| +658% | +$1.64M | 0.06% | 466 |
|
|
2018
Q4 | $292K | Sell |
156
-90
| -37% | -$168K | 0.01% | 1302 |
|
|
2018
Q3 | $579K | Buy |
246
+182
| +284% | +$428K | 0.03% | 725 |
|
|
2018
Q2 | $219K | Sell |
64
-435
| -87% | -$1.49M | 0.01% | 1292 |
|
|
2018
Q1 | $1.42M | Buy |
+499
| New | +$1.42M | 0.08% | 318 |
|
|
2017
Q2 | – | Sell |
-172
| Closed | -$433K | – | 1927 |
|
|
2017
Q1 | $433K | Buy |
172
+91
| +112% | +$229K | 0.03% | 717 |
|
|
2016
Q4 | $183K | Buy |
81
+20
| +33% | +$45.2K | 0.01% | 1298 |
|
|
2016
Q3 | $153K | Sell |
61
-45
| -42% | -$113K | 0.01% | 1361 |
|
|
2016
Q2 | $326K | Sell |
106
-19
| -15% | -$58.4K | 0.02% | 1034 |
|
|
2016
Q1 | $398K | Sell |
125
-169
| -57% | -$538K | 0.02% | 852 |
|
|
2015
Q4 | $1.51M | Buy |
294
+74
| +34% | +$379K | 0.09% | 314 |
|
|
2015
Q3 | $699K | Buy |
220
+151
| +219% | +$480K | 0.04% | 756 |
|
|
2015
Q2 | $276K | Sell |
69
-196
| -74% | -$784K | 0.01% | 1262 |
|
|
2015
Q1 | $1.06M | Buy |
265
+236
| +814% | +$942K | 0.05% | 539 |
|
|
2014
Q4 | $142K | Sell |
29
-75
| -72% | -$367K | 0.01% | 1620 |
|
|
2014
Q3 | $421K | Buy |
104
+62
| +148% | +$251K | 0.03% | 928 |
|
|
2014
Q2 | $171K | Buy |
+42
| New | +$171K | 0.01% | 1219 |
|